IGF1R and breast carcinoma: Using the BreastMark platform and the ssp2006 classifier, we examined the differences in mRNA expression of IGF1R and IR in 2185 breast cancers, including 255 basal-like breast cancers, and found that neither expression of IGF1R nor IR was elevated in a specific subtype (Fig 1).